PCSK9 and Hypercholesterolemia: To analyze the role of Epas1 in atherosclerosis, we generated Epas1EC-KO and control Epas1EC-WT mice, which were treated with AAV-PCSK9 and exposed to a HFD for 8 weeks to generate hypercholesterolemia (Figure 7A).